Cargando…
Potential dual inhibitors of PCSK-9 and HMG-R from natural sources in cardiovascular risk management
Atherosclerotic cardiovascular disease (ASCVD) stands amongst the leading causes of mortality worldwide and has attracted the attention of world's leading pharmaceutical companies in order to tackle such mortalities. The low-density lipoprotein-cholesterol (LDL-C) is considered the most promine...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Leibniz Research Centre for Working Environment and Human Factors
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859648/ https://www.ncbi.nlm.nih.gov/pubmed/35221836 http://dx.doi.org/10.17179/excli2021-4453 |